PRT2527, a Novel Highly Selective Cyclin-Dependent Kinase 9 (CDK9) Inhibitor, Has Potent Anti-Leukemic Activity in Preclinical Primary Models of Human B-ALL, T-ALL, and CLL

Autor: Neha Bhagwat, Bruce Ruggeri, Yang Zhang, Yaron Mosesson, Clare Killick-Cole, Veena Jagannathan, Peggy Scherle
Rok vydání: 2022
Předmět:
Zdroj: Blood. 140:505-506
ISSN: 1528-0020
0006-4971
DOI: 10.1182/blood-2022-158998
Databáze: OpenAIRE